Infection Surveillance Solutions Market size is assessed at USD 681.9 million in 2024 and is set to cross USD 3.4 billion by the end of 2037, witnessing more than 14.3% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of infection surveillance solutions is evaluated at USD 779.4 million.
The primary growth driver for the infection surveillance solutions market is the increasing prevalence of infectious diseases and the rising awareness of infection control in healthcare settings. This includes the need for effective monitoring and tracking of infections to improve patient outcomes, prevent outbreaks, and enhance overall healthcare quality. According to the Department of Biotechnology, Ministry of Science and Technology, Government of India, infectious diseases are among the top ten causes of death in the country, led by diarrheal diseases, neonatal disorders, lower respiratory infections, and tuberculosis.
The infection surveillance solutions market is also expanding due to an increase in hospital-acquired infections (HAIs). According to the World Health Organization (WHO), HAIs impact one out of every ten patients on average. However, in low- and middle-income nations, as well as among high-risk patients in intensive care units, the frequency may be much higher.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
14.3% |
Base Year Market Size (2024) |
USD 681.9 million |
Forecast Year Market Size (2037) |
USD 3.4 billion |
Regional Scope |
|
Component (Software, Services)
Software segment is set to capture around 54% infection surveillance solutions market share by the end of 2037, due to the growing importance of infection surveillance in the healthcare industry. Furthermore, throughout the forecast period, the market for infection surveillance services is anticipated to rise significantly due to the increasing requirement to guarantee efficient HAI management and lessen the burden of issues connected to HAI.
Deployment Mode (On-premise, Web-based)
The on-premise segment in infection surveillance solutions market is poised to garner a notable share in the forecast period. The necessity to reduce the risk of data breaches and outside attacks, as well as the requirement for safe access to healthcare IT systems are driving the segment growth. According to the World Economic Forum, in 2023, the healthcare business recorded the most expensive data breaches, with an average cost of USD 10.93 million. Thus, many healthcare businesses choose on-premise software solutions to guarantee the security of their private data. Another advantage is the potential to reuse current servers and storage gear, especially for companies upgrading or migrating from one system to another.
End use (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers)
The hospitals segment in infection surveillance solutions market is estimated to gain a significant share by 2037 due to their capacity to effectively oversee the treatment of HAIs since more procedures allow for the monitoring of more patients within the allotted period. Electronic surveillance systems are used in about 45.0% of hospitals, and this percentage is likely to rise as more rapid software tools for illness pattern analysis become necessary. To contain disease outbreaks, automated methods use simulation approaches to assess historical infection trends.
Our in-depth analysis of the infection surveillance solutions market includes the following segments:
Component |
|
Deployment Mode |
|
End use |
|
North America Market Statistics
North America infection surveillance solutions market is anticipated to account for revenue share of more than 34.5% by the end of 2037. The market is expanding due to the rising costs of HAIs, growing provider consolidation, and the increased use of healthcare IT solutions to reduce rising healthcare costs. Office of the National Coordinator for Health IT stated that nearly all non-federal acute care hospitals (96%) and 4 out of 5 office-based physicians (78%) had implemented certified electronic health records by 2021.
Federal rules for the adoption of clinical surveillance systems have led to an increasing number of hospitals and healthcare facilities in the U.S. implementing infection monitoring systems. According to the Office of Disease Prevention and Health Promotion, every year, over 680,000 illnesses and billions of dollars in additional healthcare expenses are incurred nationwide due to healthcare-associated infections (HAIs). In hospitals alone, one in every thirty-one hospitalized patients has at least one HAI at any given moment. Therefore, with infection surveillance software healthcare facilities can quickly detect infections.
In Canada, the growing prevalence of surgical site infections due to the increased number of surgeries is escalating the infection surveillance solutions market growth. Surgical site infections (SSIs) are thought to impact between 26,000 and 65,000 individuals in Canada each year.
Europe Market Analysis
The infection surveillance solutions market in Europe is expected to witness significant growth during the forecast period. The infection surveillance solutions market growth can be credited to the increasing prevalence of chronic diseases which has increased the number of surgical procedures in the region. EFPIA reported that 37% of Europeans 65 years of age and older suffer from several chronic illnesses; nevertheless, the percentage varies nearly threefold within EU member states.
In the UK, the adoption of infection surveillance solutions in healthcare settings is driven primarily by increased awareness of infection control sparked by events such as the COVID-19 pandemic. Tight regulatory mandates and technological advancements like artificial intelligence and big data analytics are also contributing factors.
Germany is implementing cutting-edge technologies, such as artificial intelligence (AI), to identify patterns in the virus's dissemination and prevent it from spreading. Researchers in this country are concentrating on creating a novel approach to infection surveillance so that it may be completed more quickly and effectively.
The leading companies in the infection surveillance solutions market are collaborating to extend their service and product offerings, as well as providing innovative treatment approaches to the industry.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?